Companies /Consumer Cyclical

Starbucks Corp

NASDAQ: SBUX Restaurants
$103.13
▼ $1.34 (−1.28%) today
Markets closed · 12:13pm ET

SBUX Coverage Page 22

8:13am ET
Companies and Brands

Nestle Adds Peanut Allergy Treatment to Its Portfolio

Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.

Paul Ausick